MTOR and type 2 diabetes mellitus: Studies have shown that obesity-induced autophagy inhibition in PTECs in type 2 diabetes patients and mice is associated with mTOR activation, and that the mTOR inhibitor rapamycin significantly improves renal autophagy deficiency in obese mice induced by a high fat diet (118).